Atlas Trials

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Clinical trial NCT04903821 · COMPLETED

Trial details

NCT number
NCT04903821
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Start date
2021-06-01
Primary completion
2022-03-15
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.